Analyst Ratings for [BLCO] Bausch + Lomb Corporation

12/11/24	Downgrades	Buy Neutral	X
BLCO Bausch + Lomb Citigroup
$24 $22
12/2/24	Downgrades	Overweight Eq-Weight	X
BLCO Bausch + Lomb Morgan Stanley
$19
10/15/24	Upgrades	In-line Outperform	X
BLCO Bausch + Lomb Evercore ISI
$19 $25
7/10/24	Initiated	Outperform	X
BLCO Bausch + Lomb Raymond James
$19
1/4/24	Downgrades	Outperform In-line	X
BLCO Bausch + Lomb Evercore ISI
$19 $17
12/12/23	Initiated	Hold	X
BLCO Bausch + Lomb Stifel
$16
10/3/23	Resumed	Outperform	X
BLCO Bausch + Lomb Evercore ISI
$20
5/30/23	Resumed	Equal-Weight	X
BLCO Bausch + Lomb Morgan Stanley
$20
3/9/23	Initiated	Hold	X
BLCO Bausch + Lomb Needham
12/21/22	Initiated	Equal Weight	X
BLCO Bausch + Lomb Barclays
$17
9/12/22	Initiated	Buy	X
BLCO Bausch + Lomb H.C. Wainwright
$21
7/26/22	Initiated	Outperform	X
BLCO Bausch + Lomb RBC Capital Mkts
$22
6/24/22	Initiated	Outperform	X
BLCO Bausch + Lomb Evercore ISI
$21
6/6/22	Initiated	Buy	X
BLCO Bausch + Lomb Citigroup
5/31/22	Initiated	Hold	X
BLCO Bausch + Lomb Deutsche Bank
$19
5/31/22	Initiated	Neutral	X
BLCO Bausch + Lomb Goldman
$22
5/31/22	Initiated	Buy	X
BLCO Bausch + Lomb Guggenheim
$24
5/31/22	Initiated	Buy	X
BLCO Bausch + Lomb Jefferies
$25
5/31/22	Initiated	Neutral	X
BLCO Bausch + Lomb JP Morgan
$20
5/31/22	Initiated	Equal-Weight	X
BLCO Bausch + Lomb Morgan Stanley
$22
5/31/22	Initiated	Overweight	X
BLCO Bausch + Lomb Wells Fargo
$23
5/11/22	Initiated	Outperform	X
BLCO Bausch + Lomb Cowen
$35

BLCO Bausch + Lomb Corporation

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

Bausch + Lomb Corporation operates as an eye health company. The Company offers eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, and ophthalmic surgical devices and instruments. Bausch + Lomb serves customers worldwide.